Invention Grant
- Patent Title: Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith
-
Application No.: US16390815Application Date: 2019-04-22
-
Publication No.: US11358952B2Publication Date: 2022-06-14
- Inventor: Matthew D. Alexander , Soraya Carranclo , Matthew D. Correa , Virginia Heather Sharron Grant , Joshua Hansen , Roy L. Harris , Dehua Huang , Timothy S. Kercher , Antonia Lopez-Girona , Mark A. Nagy , Veronique Plantevin-Krenitsky
- Applicant: Celgene Corporation
- Applicant Address: US NJ Summit
- Assignee: Celgene Corporation
- Current Assignee: Celgene Corporation
- Current Assignee Address: US NJ Summit
- Agency: Jones Day
- Main IPC: C07D403/14
- IPC: C07D403/14 ; C07D407/14 ; C07D491/10 ; C07D401/04 ; C07D401/14 ; C07D417/14 ; C07D491/08 ; C07D491/107 ; C07D498/08 ; A61P35/00
Abstract:
Provided herein are 4-aminoisoindoline-1,3-dione compounds having the following structure: wherein R, Ring A, and n are as defined herein, compositions comprising an effective amount of a 4-aminoisoindoline-1,3-dione compound, and methods for treating or preventing disorders.
Public/Granted literature
Information query
